The Other Side of the Self-Advocacy Coin: How For-Profit Companies Can Divert the Path to Justice in Rare Disease

Click to increase image sizeClick to decrease image sizeThis article is referred to by:Innovating for a Just and Equitable Future in Genomic and Precision Medicine ResearchThis article refers to:Rare Disease, Advocacy and Justice: Intersecting Disparities in Research and Clinical Care DISCLOSURE STATEMENTNo potential conflict of interest was reported by the author(s).Additional informationFundingThe author(s) reported there is no funding associated with the work featured in this article.